Literature DB >> 15289842

Relationship between HPV typing and the status of G2 cell cycle regulators in cervical neoplasia.

Yasunori Hashiguchi1, Hiroshi Tsuda, Sadako Nishimura, Takeshi Inoue, Naoki Kawamura, Kumio Yamamoto.   

Abstract

We examined human papillomavirus (HPV) typing and the status of ATM, chk2, CDC25C, cdc2 and cyclinB1 in cervical intraepithelial neoplasia (CIN) and invasive cancer (IC). A total of 93 samples [normal: 10; CIN: 34 (CINI:9, CINII:12, CINIII:13); IC: 49 (stage I:10, stage II:21, stage III:15, stage IV:3)] were included in this study. HPV status was evaluated by the PCR non-radioactive HPV detection system. We analyzed ATM, chk2, CDC25C, cdc2 and cyclinB1 protein expression by immunohistochemistry. HPV DNA was detected in 73.5% of 34 CINs and 89.8% of 49 ICs. Detection of HPV subtypes 16 and 18 was more frequent in ICs (46.9%) than in CINs (23.5%) (p=0.0387). Abnormal expression of ATM, chk2, CDC25C, cdc2 and cyclinB1 were 2.9%, 32.4%, 2.9% 20.6% and 0% in CINs and 8.2%, 30.6%, 10.2%, 46.9% and 12.2% in ICs. The alteration of cdc2 was higher in ICs than in CINs (p=0.0198). Altered expression of cdc2 was higher in HPV16 and 18 cases (69.6%) than in other cases (26.9%) (p=0.0042). However, the relationship between HPV typing and ATM, chk2, CDC25C and cyclinB1 expression was not significant. Cdc2 is implicated in cervical carcinogenesis and may be related to p53 inactivation by HPV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289842

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury.

Authors:  Hui Zhang; Qing-Qing Dong; Hua-Pan Shu; Yu-Chi Tu; Qian-Qian Liao; Li-Jun Yao
Journal:  Curr Med Sci       Date:  2022-06-09

Review 2.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

3.  Downregulation of calcineurin activity in cervical carcinoma.

Authors:  S Padma; A Pavani Sowjanya; Usha Rani Poli; Meenakshi Jain; Bn Rao; Gayatri Ramakrishna
Journal:  Cancer Cell Int       Date:  2005-04-01       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.